The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial
Background: Allergic rhinitis (AR) is an upper airways chronic inflammatory disease mediated by IgE, which affects 10%–20% of the population. The mainstay for allergic rhinitis nowadays include steroids and antihistamines, but their effects are less than ideal. Many patients therefore seek Chinese m...
Main Authors: | Pui Kuan Cheong, Tin Muk Ho, Kam Leung Chan, Cho Wing Lo, Sin Bond Leung, Kam Lun Hon, Ka Chun Leung, Tony Hon Chung Siu, Tian-He Song, Hongwei Zhang, Jessica Yuet Ling Ching, Tak Yee Chow, Chi Him Sum, Chon Pin Chia, Zhi-Xiu Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1058176/full |
Similar Items
-
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)—A double-blind, randomized, and placebo-controlled clinical trial protocol
by: Chi Him Sum, et al.
Published: (2023-01-01) -
Yupingfeng polysaccharide promote the growth of chickens via regulating gut microbiota
by: Yuling Guan, et al.
Published: (2024-02-01) -
Effects of Yupingfeng Polysaccharides as Feed Supplement on Immune Function and Intestinal Microbiome in Chickens
by: Wendan Zheng, et al.
Published: (2023-11-01) -
Effect of Yupingfeng granules combined with glucocorticoid on eosinophil infiltration and inflammatory factors of lavage fluid in nasal secretion of patients with allergic rhinitis
by: Rong HU, et al.
Published: (2023-11-01) -
Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study
by: Ma JF, et al.
Published: (2018-10-01)